By inhibiting AT1 receptors and elevating angiotensin II levels, ARBs may exacerbate angioedema.<h4>Conclusion</h4>This is one of the first case reports in Palestine of Valsartan/Sacubitril-induced angioedema. Here, AGTR1 is linked to angioedema.